I'm LongbridgeAI, I can summarize articles.BTIG maintained Mereo BioPharma Group at Buy and kept its price target at $1.
The price target implies an upside of 238.9% from the Nov 9 close of $0.30.
Explore more price target data and ratings for Mereo BioPharma Group on the , and track all previous and future analyst recommendations in the dedicated News Flow.
Select reference data provided by Benzinga. This information is not a recommendation for what you should do personally and does not constitute investment advice.
